Ocular Therapeutix (OCUL) Change in Acquisitions & Divestments (2015 - 2017)

Ocular Therapeutix has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $3.0 million in Q3 2017.

• For the quarter ending Q3 2017, Change in Acquisitions & Divestments fell 79.57% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2017 stood at $38.2 million (down 52.65% YoY), and the FY2017 full-year result was $38.2 million, down 52.65% from the prior year.
• Change in Acquisitions & Divestments for Q3 2017 stood at $3.0 million, down from $22.7 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $30.0 million in Q3 2015, with the low at $3.0 million in Q3 2017.
• Average Change in Acquisitions & Divestments over 3 years is $18.2 million, with a median of $16.0 million recorded in 2016.
• Year-over-year, Change in Acquisitions & Divestments increased 6.67% in 2016 and sank 79.57% in 2017.
• Tracing OCUL's Change in Acquisitions & Divestments over 3 years: stood at $15.0 million in 2015, then grew by 6.67% to $16.0 million in 2016, then plunged by 81.25% to $3.0 million in 2017.
• The last three Change in Acquisitions & Divestments figures came in at $3.0 million (Q3 2017), $22.7 million (Q2 2017), and $12.5 million (Q1 2017), per Business Quant data.

Peer Comparison